Introduction
Non-traumatic avascular necrosis of the femoral head (N-ANFH) usually affects adults of young/middle age and occurs bilaterally. An increasing incidence of idiopathic cases has been reported, but steroid and immunosuppression therapy (e.g., transplant patients), alcohol misuse and chemotherapy remain important causes. Early diagnosis is essential to allow for joint preserving surgical management attempts. Femoral head collapse commonly occurs within 2 years after onset and necessitates total hip arthroplasty (THA).
The German S3 guidelines have been developed under the patronage of the German society for Orthopaedics and Traumatology (DGOOC) and the German societies of Radiology (DRG), of Physical Therapy and Rehabilitation (DGPMR) and Osteology (DVO). The up to date evidence was reviewed in 2013 in order to establish the current status of diagnosis and management of N-ANFH, both in terms of conservative/pharmacological and stage-dependent surgical management.
The purpose of this review to provide a concise summary of the originally in German published S3 guidelines in English to reach a wider readership. The full length S3 guidelines from 2014 (http://www.awmf.org/leitlinien/detail/ll/033-050.html) give 38 evidence based recommendations, some of which have already published in German sub-specialty journals [1] [2] [3] [4] .
Materials and methods
An extensive literature search of all topic relevant and related published articles was carried out using internet sites of the AWMF (''Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.'' or Association of the Scientific Medical Societies in Germany) [5] , the ''National Guideline Clearinghouse'' and the ''Guidelines International Network'', a further systematic literature search was done using the data bases of the US National Library of Medicine National Institutes of Health (http://www.ncbi.nlm.nih.gov/pubmed) and the Cochrane Library (www.cochranelibrary.com). The following keywords were used ''Femur Head Necrosis'' [Majr:NoExp] NOT ''Legg-Perthes Disease'' [Mesh] capturing the period from January 1, 1970 to May 31, 2013.
• The inclusion and exclusion criteria are presented in Table 1 .
• A limitation to randomised studies was not feasible due to the lack of sufficient numbers and hence per reviewed publications of lower evidence level had to be included.
• The level of evidence (LoE) as defined by the Scottish
Intercollegiate Guidelines Network (SIGN) [6] was applied.
• Furthermore clinical relevance, study endpoints, clinical applicability, patient preference and ethics and economic aspects were evaluated.
• For the expert consensus based recommendations (ER) the AMFW Grading System [AWMF 2012] was used: ''A = must'', ''B = should'', ''0 = may''.
• The strength of participating expert consensus (EC) was judged as ''strong'' (agreement [95 %) and ''medium'' (agreement 75-95 %).
• In cases of discrepancies between LoE and recommendation grade the specific reasons were stated in the original S3 guideline (http://www.awmf.org/leitlinien/ detail/ll/033-050.html).
Results
The search revealed a total of 3715 articles (1606 prior to 1991 and 2109 from 1991 to May 31, 2013), of which 422 were pre-selected. Based on the criteria set out in Table 1 , a total of 159 articles (43 in relation to national history and conservative management, 72 in relation to diagnosis/ imaging and 64 in relation to operative intervention) were included for detailed evaluation.
The relevant findings and conclusions are presented on a point-by-point basis with the respective level of evidence (LoE) and recommendation grade (EC). Relevant important literature is quoted where necessary. 
Diagnosis of N-ANFH: imaging

Diagnostic challenges/differential diagnoses
• Transient osteoporosis of the hip (TOH) is an important differential diagnosis (DD). A diffuse oedema pattern on MRI may be seen in both entities, but a more patchy pattern and the absence of focal defects and subchondral changes is suggestive of TOH (EC ''medium'') [55-69]. • There is no scientific evidence for efficacy of Tantalum-implants and the avascular necrosis rod, which are not recommended (LoE 2?, ER B, EC ''strong'') [148, 149] Total hip replacement: outcome and implant fixation
Results after primary THR and risk factors for revision
• Revision rates after THR for N-ANFH have significantly fallen since 1990 and are now similar to global failure rates reported nationally [122, [150] [151] [152] .
• The short-, medium-and long-term results after THR for N-ANFH are comparable to outcome after THR for osteoarthritis [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] .
• THR after preceding procedures, i.e., fibular graft and osteotomies, maybe more complex [153] .
• All types and stages of femoral head necrosis can be treated successfully with THR, but less favourable clinical outcome has to be expected in alcohol or steroid related N-ANFH [153] [154] [155] [156] .
• The main risk factor for premature failure and reoperation/implant revision is the young patient age. The revision risk also seems to depend on the underlying aetiology: higher failure rates occur with sickle cell disease, Gauchers disease, renal failure or in patients after renal transplant surgery (LoE: 2? to 2??, EC ''strong'') [153] [154] [155] [156] .
Prothesis type/mode of fixation
• Similar outcome can be expected after implantation of cemented and uncemented THR, both of which are recommended as the gold standard (LoE 2? to 2??, ER B, EC ''strong'') [153, 158, 160, 164, 165] .
• Hip resurfacing in younger men (\55 years) can be considered if femoral head quality is adequate for implant fixation. Metal ion wear related complications must be discussed (LoE 2? to 2??, ER 0, EC ''strong'') [159, 160] .
• No sufficient evidence currently exists to support recommendation of short femoral stem designs [153] . 
